Nick Pizzie
Chief Financial Officer
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Axsome Therapeutics, Inc. (AXSM) | C.P.A., M.B.A. Chief Financial Officer | $530,000 | $3,730,519 |
| 2024 | Axsome Therapeutics, Inc. (AXSM) | C.P.A., M.B.A. Chief Financial Officer | $505,000 | $3,756,389 |
| 2023 | Axsome Therapeutics, Inc. (AXSM) | C.P.A., M.B.A. Chief Financial Officer | $485,000 | $3,565,817 |
| 2022 | Axsome Therapeutics, Inc. (AXSM) | C.P.A., M.B.A. Chief Financial Officer | $451,000 | $3,333,457 |
| 2021 | Axsome Therapeutics, Inc. (AXSM) | C.P.A., M.B.A. Chief Financial Officer | $409,000 | $4,228,710 |
| 2020 | Axsome Therapeutics, Inc. (AXSM) | C.P.A., M.B.A. Chief Financial Officer | $375,000 | $2,365,005 |
| 2019 | Axsome Therapeutics, Inc. (AXSM) | C.P.A., M.B.A. Chief Financial Officer | $325,000 | $1,569,837 |
| 2018 | Axsome Therapeutics, Inc. (AXSM) | C.P.A., M.B.A. Chief Financial Officer | $203,125 | $687,981 |
Earnings-call appearances
-
Axsome Therapeutics to Report Second Quarter 2026 Financial Results on August 102026-08-10
Axsome Therapeutics, Inc. (AXSM)
-
Goldman Sachs 47th Annual Global Healthcare Conference2026-06-08
Axsome Therapeutics, Inc. (AXSM)
-
Jefferies Global Healthcare Conference2026-06-04
Axsome Therapeutics, Inc. (AXSM)
-
William Blair 46th Annual Growth Stock Conference2026-06-03
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q1 FY2026 Earnings Call2026-05-04
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q4 FY2025 Earnings Call2026-02-23
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q3 FY2025 Earnings Call2025-11-03
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q2 FY2025 Earnings Call2025-08-04
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q1 FY2025 Earnings Call2025-05-05
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q4 FY2024 Earnings Call2025-02-18
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q3 FY2024 Earnings Call2024-11-12
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q2 FY2024 Earnings Call2024-08-05
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q1 FY2024 Earnings Call2024-05-06
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q4 FY2023 Earnings Call2024-02-20
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q3 FY2023 Earnings Call2023-11-06
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q2 FY2023 Earnings Call2023-08-07
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q1 FY2023 Earnings Call2023-05-08
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q4 FY2022 Earnings Call2023-02-27
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q3 FY2022 Earnings Call2022-11-07
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q2 FY2022 Earnings Call2022-08-23
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q1 FY2022 Earnings Call2022-05-02
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q4 FY2021 Earnings Call2022-03-01
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q3 FY2021 Earnings Call2021-11-08
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q2 FY2021 Earnings Call2021-08-09
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q1 FY2021 Earnings Call2021-05-10
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q4 FY2020 Earnings Call2021-03-01
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q3 FY2020 Earnings Call2020-11-05
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q2 FY2020 Earnings Call2020-08-10
Axsome Therapeutics, Inc. (AXSM)
-
Axsome Therapeutics, Inc. Q1 FY2020 Earnings Call2020-05-08
Axsome Therapeutics, Inc. (AXSM)